Very Early Thrombolytic Therapy in Suspected Acute Myocardial Infarction - TEAHAT

Description:

TEAHAT was a randomized, placebo-controlled trial of tissue-type plasminogen activator (t-PA) versus placebo in patients with suspected acute myocardial infarction (AMI). Electrocardiographic criteria were not required.